Trinity Biotech plc
TRIB
$0.6792
$0.000.00%
| 12/31/2022 | 09/30/2022 | ||||
|---|---|---|---|---|---|
| Revenue | 14.86% | -14.95% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 14.86% | -14.95% | |||
| Cost of Revenue | -23.25% | 28.80% | |||
| Gross Profit | 1,795.44% | -94.96% | |||
| SG&A Expenses | 97.81% | -20.27% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -33,300.00% | 0.00% | |||
| Total Operating Expenses | 5.91% | 11.19% | |||
| Operating Income | 18.14% | -538.58% | |||
| Income Before Tax | -1.04% | -2.59% | |||
| Income Tax Expenses | -850.00% | 106.90% | |||
| Earnings from Continuing Operations | -0.87% | -2.92% | |||
| Earnings from Discontinued Operations | -100.38% | 104,400.00% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -12.68% | 7.84% | |||
| EBIT | 18.14% | -538.58% | |||
| EBITDA | 19.30% | -679.66% | |||
| EPS Basic | -12.70% | 17.91% | |||
| Normalized Basic EPS | -- | -- | |||
| EPS Diluted | -12.08% | 17.48% | |||
| Normalized Diluted EPS | -- | -- | |||
| Average Basic Shares Outstanding | 0.00% | 12.24% | |||
| Average Diluted Shares Outstanding | 0.00% | 12.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
